Biohit Oyj Management
Management criteria checks 1/4
Biohit Oyj's CEO is Jussi Hahtela, appointed in Sep 2022, has a tenure of 1.67 years. directly owns 0.26% of the company’s shares, worth €80.40K. The average tenure of the management team and the board of directors is 1.7 years and 5.1 years respectively.
Key information
Jussi Hahtela
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.7yrs |
| CEO ownership | 0.3% |
| Management average tenure | 1.7yrs |
| Board average tenure | 5.1yrs |
Recent management updates
Recent updates
Biohit Oyj's (HEL:BIOBV) Solid Profits Have Weak Fundamentals
Feb 22
Biohit Oyj Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Feb 17Companies Like Biohit Oyj (HEL:BIOBV) Are In A Position To Invest In Growth
Aug 04Companies Like Biohit Oyj (HEL:BIOBV) Are In A Position To Invest In Growth
Feb 09Biohit Oyj (HEL:BIOBV) Is In A Strong Position To Grow Its Business
Aug 11Biohit Oyj (HEL:BIOBV) Is In A Strong Position To Grow Its Business
Apr 13We Think Biohit Oyj (HEL:BIOBV) Can Afford To Drive Business Growth
Dec 28CEO
Jussi Hahtela (50 yo)
1.7yrs
Tenure
Mr. Jussi Hahtela serves as Chief Executive Officer of Biohit Oyj from September 02, 2022 and serves as its President. He served as Chief Financial Officer at Biohit Oyj since June 4, 2021. He is responsib...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 36.3yrs | €14.00k | 14.16% € 4.3m | |
| President & CEO | 1.7yrs | no data | 0.26% € 80.4k | |
| Chief Financial Officer | 1.7yrs | no data | 0.11% € 32.2k | |
| Head of Global Sales & Marketing | less than a year | no data | no data | |
| Head of Diagnostics Department - Biohit Russia | 17.9yrs | no data | no data | |
| Chief Commercial Officer | less than a year | no data | 0.080% € 24.4k | |
| R&D Director | no data | no data | 0.087% € 26.5k |
1.7yrs
Average Tenure
50yo
Average Age
Experienced Management: BIOBV's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 36.3yrs | €14.00k | 14.16% € 4.3m | |
| Independent Chairman of the Board | less than a year | €8.00k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Scientific Advisor | no data | no data | no data | |
| Scientific Advisor | no data | no data | no data | |
| Independent Director | 1.9yrs | €14.00k | 0.029% € 8.7k | |
| Scientific Advisor | no data | €3.00k | 2.14% € 653.6k | |
| Independent Director | 5.1yrs | €14.00k | 0.046% € 14.1k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Director | 5.8yrs | €12.00k | no data |
5.1yrs
Average Tenure
72yo
Average Age
Experienced Board: BIOBV's board of directors are considered experienced (5.1 years average tenure).